AbCellera Biologics Inc.
ABCL
$3.65
$0.082.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 533.83M | 495.67M | 553.08M | 605.27M | 625.61M |
| Total Receivables | 153.40M | 159.36M | 153.37M | 126.61M | 92.13M |
| Inventory | 6.34M | -- | -- | -- | -- |
| Prepaid Expenses | 9.67M | 15.11M | 10.70M | 8.10M | 8.63M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M |
| Total Current Assets | 728.23M | 695.14M | 742.15M | 764.98M | 751.37M |
|
|
|||||
| Total Current Assets | 728.23M | 695.14M | 742.15M | 764.98M | 751.37M |
| Net Property, Plant & Equipment | 428.00M | 427.36M | 424.02M | 347.10M | 340.43M |
| Long-term Investments | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Goodwill | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Total Other Intangibles | 38.38M | 39.32M | 40.26M | 41.19M | 42.11M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.65M | 53.07M | 57.45M | 61.56M | 64.04M |
| Total Assets | 1.36B | 1.36B | 1.40B | 1.34B | 1.36B |
|
|
|||||
| Total Accounts Payable | 25.23M | 31.77M | 32.04M | 32.80M | 34.35M |
| Total Accrued Expenses | 10.76M | 7.23M | 4.97M | 3.19M | 8.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.82M | 5.17M | 4.90M | 4.64M | 4.62M |
| Total Finance Division Other Current Liabilities | 22.51M | 24.63M | 25.12M | 34.77M | 29.27M |
| Total Other Current Liabilities | 22.51M | 24.63M | 25.12M | 34.77M | 29.27M |
| Total Current Liabilities | 64.31M | 68.80M | 67.02M | 75.40M | 76.61M |
|
|
|||||
| Total Current Liabilities | 64.31M | 68.80M | 67.02M | 75.40M | 76.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 137.40M | 137.05M | 137.18M | 63.21M | 60.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 188.34M | 186.10M | 190.78M | 182.62M | 167.11M |
| Total Liabilities | 390.05M | 391.95M | 394.99M | 321.23M | 304.47M |
|
|
|||||
| Common Stock & APIC | 1.00B | 987.27M | 973.15M | 958.67M | 943.53M |
| Retained Earnings | -29.48M | -20.54M | 36.58M | 71.31M | 116.93M |
| Treasury Stock & Other | -4.23M | -2.70M | -2.66M | -7.00M | -4.38M |
| Total Common Equity | 966.90M | 964.04M | 1.01B | 1.02B | 1.06B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 966.90M | 964.04M | 1.01B | 1.02B | 1.06B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 966.90M | 964.04M | 1.01B | 1.02B | 1.06B |
|
|
|||||